# Raltegravir Activity In Lymphoid Tissues

> **NCT00863668** · NA · WITHDRAWN · sponsor: **University of Minnesota**

## Conditions studied

- HIV Infection
- HIV Infections

## Interventions

- **DRUG:** Efavirenz + Tenofovir DF/Emtricitabine
- **DRUG:** Raltegravir + Tenofovir DF/Emtricitabine
- **PROCEDURE:** Colonoscopy with biopsies
- **PROCEDURE:** Inguinal Lymph Node Excision

## Key facts

- **NCT ID:** NCT00863668
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-03
- **Primary completion:** 2010-03
- **Final completion:** 2011-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00863668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00863668, "Raltegravir Activity In Lymphoid Tissues". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00863668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*